Journal
FRONTIERS IN PHARMACOLOGY
Volume 11, Issue -, Pages -Publisher
FRONTIERS MEDIA SA
DOI: 10.3389/fphar.2020.614928
Keywords
necroptosis; neutrophil; serine protease; signal transduction; small molecule inhibitor
Categories
Funding
- Swiss National Science Foundation [31003A_173215, 310030_184816]
- European Union Horizon 2020 Research and Innovation Program (Marie Sklodowska-Curie grant) [642295]
- Slovenian Research Agency [P20208]
- Austrian Science Fund (FWF) [P20208] Funding Source: Austrian Science Fund (FWF)
Ask authors/readers for more resources
This study demonstrates that serine protease inhibitors can block necrosis triggered by CD44, preventing cell death in GM-CSF-primed neutrophils. The inhibitors inhibit the activation of MLKL, p38 MAPK, and PI3K. However, they have no effect on apoptosis mediated by the FAS receptor.
Adhesion receptors, such as CD44, have been shown to activate receptor interacting protein kinase-3 (RIPK3)-mixed lineage kinase-like (MLKL) signaling, leading to a non-apoptotic cell death in human granulocyte/macrophage colony-stimulating factor (GM-CSF) - primed neutrophils. The signaling events of this necroptotic pathway, however, remain to be investigated. In the present study, we report the design, synthesis, and characterization of a series of novel serine protease inhibitors. Two of these inhibitors, compounds 1 and 3, were able to block CD44-triggered necroptosis in GM-CSF-primed neutrophils. Both inhibitors prevented the activation of MLKL, p38 mitogen-activated protein kinase (MAPK) and phosphatidylinositol 3'-kinase (PI3K), hence blocking the increased levels of reactive oxygen species (ROS) required for cell death. Although compounds one and three partially inhibited isolated human neutrophil elastase (HNE) activity, we obtained no pharmacological evidence that HNE is involved in the initiation of this death pathway within a cellular context. Interestingly, neither serine protease inhibitor had any effect on FAS receptor-mediated apoptosis. Taken together, these results suggest that a serine protease is involved in non-apoptotic CD44-triggered RIPK3-MLKL-dependent neutrophil cell death, but not FAS receptor-mediated caspase-dependent apoptosis. Thus, a pharmacological block on serine proteases might be beneficial for preventing exacerbation of disease in neutrophilic inflammatory responses.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available